|
Cumulative incidence of neutrophil reconstruction at day + 30
|
98.3%
|
95.0%
|
0.107
|
|
Cumulative incidence of platelet reconstruction at day + 30
|
87.6%
|
80.0%
|
0.303
|
|
Median days to neutrophil reconstruction(> 0.5 × 109/L) (range)
|
12(7–34)
|
14(10–45)
|
0.005
|
|
Median days to platelet reconstruction(> 20X109/L) (range)
|
14(8–68)
|
18(8–65)
|
0.045
|
|
Acute GVHD grade II–IV
|
45(37.2%)
|
6(30%)
|
0.535
|
|
Chronic GVHD
|
67(55.4%)
|
10(50%)
|
0.655
|
|
2 year cumulative incidence of relapse
|
12.0%
|
16.8%
|
0.910
|
|
2 year non-replase mortality
|
26.0%
|
21.7%
|
0.441
|
